News & Media

    Raymond A. Dionne D.D.S., Ph.D Joins Charleston Laboratories, Inc Scientific Advisory Board
    Gary A. Peltz, M.D. Joins Charleston Laboratories, Inc Scientific Advisory Board
    Charleston Laboratories, Inc submitted a request with the U.S. Food and Drug Administration (FDA) for a Pre-Investigational New Drug (Pre-IND) meeting regarding the development of CL-H1T.
    Robert H. Dworkin, Ph.D Joins Charleston Laboratories, Inc Scientific Advisory Board
    31st Annual J.P. Morgan Healthcare Conference
    Charleston Laboratories, Inc. Appoints Ryan Baker Executive Vice President and Chief Operating Officer
    Charleston Laboratories, Inc. Appoints Bill Kozarek Ph.D Vice President of Product Development
    30th Annual J.P. Morgan Healthcare Conference
    BIO International Convention 2009
    Charleston Completes Preliminary Research on Nausea-Prone Questionnaire (NPQ)
    Charleston Labs begins Bioequivalence Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of CL-108
    27th Annual J.P. Morgan Healthcare Conference
    Charleston Sucessfully Completes Series A Private Placement
    Charleston Laboratories, Inc. Investigational New Drug CL-108 “Safe to Proceed Testing in Man.”
    26th Annual J.P. Morgan Healthcare Conference
    Charleston Laboratories, Inc. Appoints Bernard Schachtel, M.D. Chief Medical Officer
    Charleston Laboratories, Inc. Appoints John F. Ameling V.P of Regulatory Affairs